Efficacy and Immune Function of Pirfenidone in CTD-ILD
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A single-center randomized controlled study was used to observe the efficacy and immune
function with/wo pirfenidone on CTD-ILD patients in QIlu Hospital of Shanndong University for
24 months. The main research endpoints are lung function ,patient dyspnea score,imaging
indicators and so on.